# OnCo record briacell (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/briacell/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "briacell" ;
  schema:name "BriaCell Therapeutics"@en ;
  schema:alternateName "BriaCell Therapeutics Corp"@en, "BriaCell Therapeutics Corporation"@en, "BriaCell"@en ;
  schema:description "BriaCell Therapeutics is a listed company developing off-the-shelf immunotherapies made from cancer cells grown in the laboratory. Its lead treatment, Bria-IMT, is in a phase 3 trial in metastatic breast cancer, and a related platform, Bria-OTS, is in an earlier trial."@en ;
  schema:url <https://onco.cc/companies/briacell/>, <https://briacell.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://briacell.com/>, <https://reporter.nih.gov/project-details/11398997>, <https://clinicaltrials.gov/study/NCT06072612> ;
  schema:addressCountry "CA" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/prostate/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/shared-antigen-vaccine/> ;
  onco:drugs <https://onco.cc/drugs/bria-imt/>, <https://onco.cc/drugs/bria-ots/> ;
  onco:trials <https://onco.cc/trials/nct06072612/> .